ACRO Accepts New Members

As reported in market watch, the Association of Clinical Research Organizations (ACRO), has accepted two more members, Clinilabs, and RPS. Clinilabs specializes in dealing with the central nervous system and cardiovascular therapeutics. RPS, provides global Phase I-IV clinical development solutions.

David Spaight, ACRO Chair and President, released this statement:

"I am extremely pleased to welcome Clinilabs and RPS as new members of ACRO. Their involvement will enhance the association's ability to represent the CRO industry broadly to government officials, research sponsors, patient groups, and others international stakeholders. We invite all CROs to consider membership in our industry's trade association."